Efficacy and Tolerability of Hyaluronan (ialuset®) in the Treatment of Pressure Ulcers
Tóm tắt
Background: Pressure ulcers are complex chronic wounds and a frequent cause of morbidity in elderly subjects in hospitals and nursing homes. Local treatment is based on the use of dressings that protect the wound and provide a favourable environment for healing to occur. ialuset®, a treatment based on hyaluronan (hyaluronic acid), is already available on the market and known to be an effective treatment for venous leg ulcers. However, no clinical trials of hyaluronan as a treatment option for pressure ulcers have been reported as yet.
Methods: The purpose of this review was to investigate the efficacy and tolerability of ialuset® in the treatment of pressure ulcers. To this end, this article reports data from 21 predominantly elderly patients with National Pressure Ulcer Advisory Panel grade II, III or IV pressure ulcers treated with ialuset® cream or gauze pads over a 3-week period in ten hospitals in France.
Results: A significant median decrease of 4cm2 in the surface area of treated wounds was observed after 3 weeks of ialuset® use (p < 0.05 vs baseline). A ≥50% reduction in pressure ulcer surface area was seen in 65.0% of patients (95% CI 44.8, 84.3). Nine patients (45%) showed a ≥50% increase in epithelial surface compared with the initial lesion. Patient-reported pain appeared to decrease during the 3-week treatment period, although this decrease did not quite reach statistical significance (p = 0.07). Additionally, a significant decrease in the mean percentage of fibrous tissue in the wound was observed (p = 0.02), as was a nonsignificant increase in granulation tissue (p = 0.1). General efficacy was considered as good or very good for nearly all patients on review of the data (19/20 patients as assessed by clinicians). Overall tolerability was also considered good or very good in 12/15 assessments by patients at day 21.
Conclusion: These preliminary findings suggest that ialuset® is a promising option in the treatment of pressure ulcers; however, further investigation in the form of large, randomised clinical trials is required before firm conclusions can be drawn regarding the efficacy and tolerability of this treatment in this context.
Tài liệu tham khảo
Allman RM. Pressure ulcer prevalence, incidence, risk factors and impact. Clin Geriatr Med 1997; 13: 421–36
Barrois B, Allaert FA, Colin D. A survey of pressure sore prevalence in hospitals in the greater Paris region. J Wound Care 1995 May; 4 (5): 234–6
Smith DM. Pressure ulcers in the nursing home. Ann Intern Med 1995; 123: 433–42
Thoroddsen A. Pressure sore prevalence: a national survey. J Clin Nurs 1999; 8: 170–9
Whittington K, Patrick M, Roberts JL. A national study of pressure ulcer prevalence and incidence in acute care hospitals. J Wound Ostomy Continence Nurs 2000; 27 (4): 209–15
Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994; 130 (4): 489–93
Hinman CD, Maibach H. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963; 200 (4904): 377–8
Winter GD. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293–4
Winter GD. Effect of air exposure and occlusion on experimental human skin wounds. Nature 1963; 200: 378–9
Harding KG, Morris HL, Patel GK. Science, medicine, and the future: healing chronic wounds. BMJ 2002; 324: 160–3
Hollisaz MT, Khedmat H, Yari F. A randomized clinical trial comparing hydrocolloid, phenytoin and simple dressings for the treatment of pressure ulcers [ISRCTN33429693]. BMC Dermatol 2004; 4 (1): 18
Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen 1999; 7 (2): 79–89
Humbert P. City/hospital networks for leg ulcers and treatment with ialuset. Ann Dermatol Venereol 2002; 129 (10 Pt 2): 1231–4
Ortonne JP. A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers. J Dermatol Treat 1996; 7: 75–81
National Pressure Ulcer Advisory Panel (NPUAP). Pressure ulcers prevalence, cost and risk assessment: consensus development conference statement. Decubitus 1989; 2 (2): 24–8
Breslow N, Day N. Statistical methods in cancer research: II. The design and analysis of cohort studies. IARC Sci Pub 1987; 82: 1–406
Rhodes RS, Heyneman CA, Culbertson VL, et al. Topical phenytoin treatment of stage II decubitus ulcers in the elderly. Ann Pharmacother 2001; 35: 675–81
Müller E, van Leen MWF, Bergemann R. Economic evaluation of collagenase-containing ointment and hydrocolloid dressing in the treatment of pressure ulcers. Pharmacoeconomics 2001; 19 (12): 1209–16